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Abstract
Background: The purpose of this study was to characterize patients with chronic temporomandibular disorders
(TMD) in terms of existing hyperalgesia against cold, heat and pressure.
Methods: The extent of hyperalgesia for pressure and thermal sensation in TMD patients was determined by the
use of the painDETECT questionnaire ("Is cold or heat in this area occasionally painful?” “Does slight pressure in this
area, e.g., with a finger, trigger pain?") and experimental somatosensory testing against thermal and pressure stimuli
(Quantitative Sensory Testing; QST). In addition, we explored psychological comorbidity among the chronic TMD patients
(hospital anxiety and depression scale, HADS-D and coping strategies questionnaire, CSQ).
Results: Nineteen patients with chronic TMD and 38 healthy subjects participated in the study. N = 12 patients
had a painDETECT score≤ 12, n = 3 patients had a painDETECT score of 13–18 and n = 4 patients had a painDETECT
score≥ 19. TMD patients with painDETECT scores ≥19 had moderately, strong or very strong enhancement of thermal
and pressure pain perception, whereas patients with painDETECT scores 13–18 and≤ 12 responded these questions
with “never”, “hardly noticed” or “slightly painful” (p < 0.05–0.01). With increasing painDETECT scores we found
increased hyperalgesia for pressure (p < 0.01) and thermal stimuli (p < 0.05) in QST. The patients with a painDETECT
score≥ 19 showed increased signs of anxiety (p < 0.05), depression (p < 0.01), praying and hoping (p < 0.05).
Conclusion: The present study has shown that the PainDETECT questionnaire can be a helpful additional diagnostic
tool. Together with QST, the PainDETECT questionnaire detected hyperalgesia for pressure and thermal sensation.
Therefore the PainDETECT questionnaire is helpful to decide which TMD patients should undergo QST.
Keywords: Temporomandibular disorder (TMD), Quantitative sensory testing (QST), PainDETECT questionnaire,
Stress-induced hyperalgesia
Background
Temporomandibular disorder (TMD) is an umbrella term
for various pathological conditions characterized by pain
and/or dysfunction of the masticatory muscles and/or the
temporomandibular joint [1–4]. TMD is the major cause
of non-dental chronic facial pain [1, 2, 5] with an esti-
mated prevalence of 3 to 5% in the general population [5].
Since the aetiology of TMD is multidimensional, including
physiological, structural, postural, psychological and gen-
etic factors [4, 6–8], a complex diagnostic approach for
TMD is required in clinical diagnostics, treatment and re-
search [9, 10]. Notably, the population with chronic myo-
genic TMD is very heterogeneous [11, 12]. Apart from
“sensitive” and “insensitive” myogenic TMD pain patients,
as found in a previous study [11], there were also TMD
patients who respond or not to standard conservative
therapy alone or in combination with cognitive behavioral
therapy [12]. The characteristics of “non-responding” pa-
tients did not differ on demographics or temporoman-
dibular joint pathology, but showed higher psychological
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comorbidity such as poorer coping strategies and higher
levels of catastrophizing [12]. At the same time, psycho-
logical distress such as depression, anxiety, and
somatization contribute to the progression of TMD [8,
13–15], whereby effective pain management is compli-
cated due to the interaction of all these factors [16, 17].
Repeated episodes of pain and continuous nociceptive in-
put may shift the balance of central modulation, contrib-
uting to sustained chronic pain [18]. For these patients,
spontaneous pain most often is not only present in the
area of the trigeminal nerve, but throughout the whole
body. This condition is called hyperalgesia and can be
interpreted as central sensitization with insufficient en-
dogenous descending inhibition [11, 18] and is induced by
persistent psychosocial stress and increased mental vul-
nerability [19, 20]. Stress and anxiety exert modulatory in-
fluences on pain depending on the nature, duration and
intensity of the stressor and developmental influences on
the maturation of the stress and pain system [21]. In this
context there is a bidirectional relationship between psy-
chological comorbidity and spontaneous myogenic pain.
To reveal such stress-induced hyperalgesia, a comprehen-
sive analysis of the medical history and a careful clinical
examination is required in the diagnostic process of
chronic TMD patients.
The purpose of this study was to characterize patients
with chronic myogenic TMD in terms of existing hyper-
algesia for pressure and thermal sensation.
With the painDETECT questionnaire it is possible to
ask for the subjective rating of the patient of the extent
of hyperalgesia to cold or heat and pressure. Those mo-
dalities can also be experimentally assessed with the
Quantitative Sensory Testing (QST) protocol.
Furthermore, we looked for psychological comorbidity
among the TMD patients as trigger factors of hyperalgesia.
Methods
The study followed the 1964 Declaration of Helsinki on
medical protocol and ethics. Ethical approval was obtained
from the local ethical committee (ethics committee of
Rhineland-Palatinate, no.837.067.09 (6572)). The study
was designed as a prospective clinical monocenter study
at the Department of Oral and Maxillofacial Surgery,
University Medical Centre of the Johannes Gutenberg
University of Mainz, Germany. Written consent was ob-
tained from all patients and volunteers prior to the study.
Patients
Nineteen patients with myogenic temporomandibular
disorders (TMD) were selected from the pain outpatient
clinic of the Department of Oral and Maxillofacial
Surgery, University Medical Centre of the Johannes
Gutenberg University of Mainz, Germany as diagnosed
by one investigator (MD) using the Research Diagnostic
Criteria for TMD [22]. Inclusion criteria were chronic
uni- or bilateral myogenic pain (duration ≥6 months).
Only patients with bilateral intact or prosthetically sup-
ported occlusion were included. Diseases that interfere
with pain perception or cause pain in other body regions
were an exclusion criterion. Also excluded were patients
consuming antidepressant or anticonvulsive drugs, as
well as those having taken drugs influencing pain per-
ception (analgesics) within the last 24 h.
TMD patients underwent careful clinical examination
as stated below to reveal abnormalities in facial sensibil-
ity, muscle and temporomandibular joint sensitivity to
palpation, mandibular movement and auscultation of the
joint. Additionally, comprehensive medical history as
well as pain history was documented on paper-based
charts. QST was performed and the psychological co-
morbidity determined.
We first analysed the patients as a collective group
(TMD all) and then divided them into 3 groups depending
on the patient’s painDETECT score (≤ 12, n = 12; 13–18,
n = 3; ≥ 19, n = 4).
Control group (healthy subjects)
Patients were compared to healthy subjects who had had
no temporomandibular disorder complaints during the
last 6 months. Healthy subjects were recruited by an an-
nouncement in the department of Oral and Maxillofacial
Surgery, University Medical Centre of the Johannes
Gutenberg University of Mainz, Germany. Patients were
compared related to clinical investigation, QST values
and psychological comorbidity. Included were healthy
subjects not having taken drugs influencing pain percep-
tion (analgesics) within the last 24 h.
Clinical investigation
Patients and healthy subjects were examined by one in-
vestigator (MD) according to dental and clinical factors
to reveal abnormalities in countenance, mandibular
movement, auscultation of the jaw, tension of the facial
muscles, and facial sensitivity. Examination was carried
out as described in Pfau et al. 2009 [11].
For intraoral dental examination, the dentition and
static contacts were noted as well as signs of oral habits.
We determined the total number of missing teeth, the
number of missing teeth having been replaced by remov-
able dentures or bridges, and the numbers of crowned
or filled teeth. Distances of overbite, overjet and interoc-
clusal distances were measured. For extraoral examin-
ation, we tested the functions of muscles, nerves and the
movements of the temporomandibular joint. We investi-
gated the function of the facial nerve and the sensitivity
to pressure over trigeminal foramina. Signs of underlying
myogenic orofacial hyperactivity were documented after
checking the mimic muscles, masticatory and neck
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muscles. Temporalis, masseter muscle, sternocleidomas-
toid muscle, muscles of the cervical spine, trapezius
muscle and suprahyoidal muscles were palpated with the
fingertips of the index and the third finger, using the
non-dominant hand of the investigator to fix the head
e.g. the mandible. For palpation of the extra oral muscles
we used an approximate pressure of ~ 10 N, for intraoral
muscle and joint palpation an approximate pressure of
~ 5 N. We checked if a single active mandibular move-
ment (forward movements, laterotrusion and mouth
opening) or an assisted backward movement was painful.
The diagnostic findings (unpleasant, painful, trigger
point) during palpation of temporalis, medial and lateral
pterygoid and masseter muscle were also documented.
Pain history and current pain
The medical records and pain history of the patients
were taken in a written form and completed verbally. Pa-
tients were asked to answer different questionnaires on
pain, including questions on pain intensity, pain dur-
ation, and pain localisation. We used the Berne pain
questionnaire (BPQ, paper-based chart) consisting of 20
groups of sensory, affective, and evaluative items to de-
scribe the quality and intensity of the pain [23] and the
painDETECT paper-based form [24]. The painDETECT
questionnaire was developed and validated for patients
with neuropathic pain and is increasingly applied to pa-
tients with back pain [25, 26]. It consists of questions
concerning estimation of pain intensity, pain duration,
pain patterns (persistent pain and or pain attacks) and
pain quality (burning, tingling or prickling sensation,
numbness, and temperature and pressure hyperalgesia).
We used the painDETECT questionnaire as it contains
questions concerning hyperalgesia against cold or heat
and pressure (“Is cold or heat in this area occasionally
painful?” “Does slight pressure in this area, e.g., with a
finger, trigger pain?”) Patients were divided into 3 groups
according to their PainDETECT score. In the group
“≤ 12” a neuropathic component is unlikely, in the group
“≥ 19” a neuropathic component is likely, and in the group
“13–18”, it is uncertain whether a neuropathic component
exists. The painDETECT questionnaire demonstrated
satisfactory reliability [27], showing accurate test-retest
stability as a prerequisite for use in repeated measure-
ments [25].
Psychological testing
In order to assess psychological comorbidity, patients
and healthy subjects were asked questions relating to
coping strategies (CSQ, full paper-based version), and
questions on anxiety and depression disorders
(HADS-D; hospital anxiety and depression scale,
German version, full paper-based charts).
Quantitative sensory testing (QST)
Changes of thermal and mechanical detection and pain
thresholds were examined using the Quantitative Sensory
Testing protocol according to the DFNS (Deutscher
Forschungsverbund Neuropathischer Schmerz), described
in detail by Rolke et al. [28, 29] and Hartmann et al. [30].
The QST protocol consists of the following parameters:
CDT (cold detection threshold); WDT (warm detection
threshold); TSL (thermal sensory limen); PHS (paradoxical
heat sensation); CPT (cold pain threshold); HPT (heat
pain threshold); MDT (mechanical detection threshold);
MPT (mechanical pain threshold); MPS (mechanical pain
sensitivity); DMA (dynamic mechanical allodynia); WUR
(wind up ratio); VDT (vibration detection threshold) and
PPT (pressure pain threshold).
All patients and healthy subjects underwent the same
QST protocol. They were tested on the left and on the
right masseter muscles by one trained examiner within
one experimental session, which took roughly 60 min.
In a first step, the patients were examined as a whole
group and then divided into 3 groups according to their
painDETECT score (≤ 12; 13–18; ≥ 19).
Z-transformation of QST data
To compare patients’ QST data profiles with the age and
gender-matched healthy subjects, reference data of
healthy subjects were used to normalize test results of
patients by calculating the z-transform: Z = (value
(patient) – mean (healthy subjects))/ standard deviation
(healthy subjects). This procedure results in a QST pro-
file where all parameters are presented as standard nor-
mal distributions (zero mean, unit variance). Z-values
above “0” indicate a gain of function when the single pa-
tient is more sensitive to the tested stimuli compared
with controls (hyperalgesia, allodynia, hyperpathia),
while Z-scores below “0” indicate a loss of function re-
ferring to a lower sensitivity of the patient (small and
large fibre functions). A Z-score of zero represents a
value corresponding to the group mean of the healthy
control subjects.
Statistical analysis
QST data analysis
Data evaluation was performed according to the stan-
dardized protocol of the German Research Network on
Neuropathic Pain [28, 29]. All data were normally dis-
tributed in log-space and were transformed logarithmic-
ally before statistical analysis, with the exception of the
CPT, HPT and VDT number, which were normally dis-
tributed as raw data. All statistical calculations were per-
formed using SPSS software (IBM SPSS Statistics 23) or
Excel for Windows (Microsoft Excel 2010). All data are
presented as mean ± standard error of the mean (SEM).
Differences of QST data between patient groups and
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control group (healthy subjects) were determined using an
unpaired t-test, considering the Levene’s test for equality
of variances for comparison of TMD all with healthy sub-
jects or analysis of variance (ANOVA) with LSD post hoc
corrections of multiple comparisons for comparison of
the different painDETECT subgroups with healthy sub-
jects. The significance level was set at p < 0.05.
Data of clinical examination and questionnaires
All statistical calculations were performed using SPSS
software (IBM SPSS Statistics 23) or Excel for Windows
(Microsoft Excel 2010). All data are presented as mean ±
standard deviation (SD). Differences between patient groups
and control group (healthy subjects) were determined using
an unpaired t-test, considering the Levene’s test for equality
of variances for comparison of TMD all with healthy sub-
jects or analysis of variance (ANOVA) with LSD post hoc
corrections of multiple comparisons for comparison of the
different painDETECT subgroups with healthy subjects.
The level of significance was set at p < 0.05.
Results
Patients
Nineteen patients with myogenic temporomandibular
disorders (TMD) were included as diagnosed by one in-
vestigator (MD) using the Research Diagnostic Criteria
for TMD [22]. The patients (13 women, 6 men) had a
mean age of 52.2 ± 14.9 years. Fifteen patients had uni-
lateral symptoms of temporomandibular disorder, 7 pa-
tients on the left side, 8 patients on the right side and 4
patients had bilateral findings.
Control group (healthy subjects)
Thirty-eight healthy subjects (33 women, 5 men) with a
mean age of 46.7 ± 13.3 years were included.
Clinical findings
TMD patients (TMD all)
Regarding the patients with chronic TMD in its entir-
ety (TMD all) we found no changes in the function
of mimic muscle. TMD patients (TMD all) showed
increased sensitivity towards palpation of the trigemi-
nal foramina, but only palpation of the left infraorbi-
tal foramen was significantly more painful (p < 0.05).
TMD patients (TMD all) showed increased sensitivity
towards palpation of the masticatory muscles. In particu-
lar, the pain values for the temporalis (left p < 0.05; right
p < 0.001), the masseter (left p < 0.05; right p < 001,
masseter left + right p < 0.01, Fig. 1a) and the sterno-
cleidomastoid muscle (left p < 0.05; right p < 0.01)
were increased. It should be noted that, with regards to
the palpation of the masticatory muscles, particularly the
masseter, that also the healthy subjects (n = 12, 31%)
showed pain upon palpation. TMD patients (TMD all)
showed increased sensitivity to palpation of the temporo-
mandibular joint (p < 0.01), particularly during dorsal pal-
pation. Furthermore, TMD patients (TMD all) showed
pain when opening the mouth (p < 0.01) and during later-
otrusion (p < 0.01).
TMD subgroups as a function of painDETECT scores
Examining the patients with chronic TMD according to
their painDETECT scores, we found patients within the
“painDETECT ≥ 19” subgroup showing notably increased
sensitivity towards palpation of the temporalis (left
p < 0.001; right p < 0.001), the sternocleidomastoid muscle
(left p < 0.05; right p < 0.01) and the masseter muscle (left
p < 0.01; right p < 0.001; masseter left + right p < 0.001,
Fig. 1a). Furthermore, sensitivity towards palpation of the
temporomandibular joint was enhanced in the “painDE-
TECT ≥ 19” subgroup (lateral p < 0.05 and dorsal p <
0.01). In addition, opening the mouth was painful (p <
0.05) and forward movements (protrusion; p < 0.001) in
the TMD subgroup with painDETECT scores ≥ 19.
QST findings
TMD patients (TMD all)
The significant differences in masseter pressure pain
sensitivity found in clinical examination for the TMD
patients in its entirety (TMD all), compared to the
healthy subjects (Fig. 1a), p < 0.01), could not be con-
firmed in QST pressure pain thresholds (PPT) (Fig. 1b,
Table 1). Furthermore, there were no differences for all
other QST parameter, except for VDT, whereby the
TMD patients showed a higher sensitivity than the
healthy subjects (Table 1, p < 0.05).
TMD subgroups as a function of painDETECT scores
When analysing the results of patients with chronic
TMD according to their painDETECT scores, we found
similar results for palpation of the masseter muscle (Fig.
1a), whereas totally different results emerged for the
QST PPT values. In QST we found the TMD patients
with a painDETECT score ≥ 19 showing significant
higher sensitivity to pressure (PPT) compared to healthy
subjects (Fig. 1b, Table 1, p < 0.01). Patients with a pain-
DETECT score ≥ 19 were also significantly more sensi-
tive to painful cold (CPT) and painful heat (HPT)
compared to healthy subjects (Fig. 2, Table 1, p < 0.05; p
< 0.05), whereas patients showing painDETECT scores
≤ 12 were less sensitive to cold (CPT) than healthy sub-
jects (Fig. 2, Table 1, p < 0.05). The results underline the
finding that TMD pain patients appear to be a heteroge-
neous group.
Findings of the painDETECT questionnaire
An analysis of the individual answers from the painDE-
TECT questionnaire revealed similar variation in
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severity of pain perceptions for the distinct TMD groups
(painDETECT ≤ 12; 13–18; ≥ 19). Particularly answers to
questions concerning hyperalgesia, such as, “Is cold or heat
in this area occasionally painful?”, “Does slight pressure in
this area, e.g., with a finger, trigger pain?” [24] revealed that
TMD patients with painDETECT scores ≥ 19 had moder-
ately, strong or very strong enhancement of pain percep-
tion, whereas patients with painDETECT scores 13–18
and ≤ 12 answered these questions with “never”, “hardly no-
ticed” or “slightly painful” (p < 0.05–0.01, Fig. 3).
Pain history and current pain
All TMD patients with painDETECT scores ≥ 19 re-
ported additional pain in other body regions already last-
ing for years (Table 2). On a numeric rating scale (NRS
0–10), the group with painDETECT scores ≥ 19 quoted
the lowest present pain (1.8 ± 0.9) and the lowest pain
maximum during the last week (1.8 ± 0.7) among all
TMD groups. In contrast, the painDETECT 13–18
group with pain lasting for only 6–12 months showed
the highest pain estimation for present pain (3.7 ± 1.2)
Fig. 1 a Increase of pressure pain from unpleasant over painful to trigger point on masseter muscle palpation in patients with TMD (TMD all, n = 19;
TMD subgroups concerning their painDETECT score (≤ 12, n = 12; 13–18, n = 3; ≥ 19, n = 4); mean ± SD (masseter left + right); b QST-pressure pain
threshold (PPT) presented as z-score values (mean value of patients (masseter left + right) - mean controls (masseter left + right)/SD controls).
A z-score of 0 means the score is the same as for the mean of healthy subjects. It can also be negative or positive indicating a loss or gain of function;
p-value for TMD all as results of unpaired t-test as related to healthy subjects considering the Levene’s test for equality of variances; p-value according
to the painDETECT scores as results of analysis of variance (ANOVA) with LSD post hoc correction of multiple comparison; (n.s. = not significant,
* = p < 0.05, ** = p < 0.01, *** = p < 0.001)
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and maximal pain of the last week (6.7 ± 1.1). In
addition, this group showed the highest score for days
per year when they were unable to work (> 50) (Table 2).
Psychological comorbidity
The patients with a painDETECT score ≥ 19 showed the
highest values for anxiety (mean 9.3 ± 7.0, p > 0.05, 50%
> 10) and depression (mean 7.0 ± 3.2, p < 0.01) in the
HADS-D among the TMD painDETECT groups
(≤ 12, 13–18, ≥ 19) compared to healthy subjects
(Table 3). Significant differences were found for the
painDETECT ≥ 19 group for praying and hoping (CSQ5)
(mean 4.1 ± 0.9, p < 0.05). The painDETECT group ≤ 12
showed significant values for catastrophizing (CSQ6)
(mean 3.6 ± 2.1, p < 0.05) and the painDETECT group
13–18 showed significant values for increased behaviour
activities (CSQ7) (5.4 ± 0.8, p < 0.05) (Table 3).
Discussion
The present study disclosed pronounced somatosensory
changes in a subgroup of TMD patients identified by
their scores in the painDETECT questionnaire.
Fig. 2 Thermal hyperalgesia in patients with myogenic TMD concerning their painDETECT score (≤ 12, n = 12; 13–18, n = 3; ≥ 19, n = 4) a QST-
Cold pain threshold (CPT) and b QST-Heat pain threshold (HPT) presented as z-score values (mean value of patients-mean controls/SD controls).
A z-score of 0 means the score is the same as for the mean of healthy subjects. It can also be negative or positive indicating loss or gain of
function; Significance as results of analysis of variance (ANOVA) with LSD post hoc correction of multiple comparison; (n.s. = not significant,
* = p < 0.05, ** = p < 0.01, *** = p < 0.001)
Fig. 3 Variation of sensorial and pain perception in patients with myogenic TMD concerning their painDETECT score (≤ 12, n = 12; 13–18, n = 3;
≥ 19, n = 4); Variation of severity of sensational (dysaesthesia, numbness) and pain perception (allodynia, hyperalgesia) as revealed by the
painDETECT questionnaire (1 = never, 2 = hardly noticed, 3 = slightly, 4 =moderately, 5 = strongly, 6 = very strongly); mean ± SD; Significance as
results of analysis of variance (ANOVA) with LSD post hoc correction of multiple comparison (*p < 0.05; **p < 0.01; ***p < 0.001)
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Somatosensory changes in this subgroup with painDE-
TECT scores ≥ 19 consisted of lowered thresholds for
pressure pain as well as for cold and heat stimuli in the
Quantitative Sensory Testing (QST). Additionally, in the
painDETECT questionnaire, the questions concerning
sensory gain (hyperalgesia) in particular were answered
with high values. Similarly, Herpich et al. found that pa-
tients with more severe signs and symptoms of TMD
had a lower pressure pain threshold [31]. Such somato-
sensory changes result in amplification of nociception,
which promotes and sustains chronic pain states [18].
As we believe stress-induced sensitisation to be one
Table 2 Pain estimation of TMD patients (TMD all and according to their painDETECT scores (≤ 12, n = 12; 13–18, n = 3; ≥ 19, n = 4));
pain estimation in mean value ± SD or in mean % of 100%
Pain estimation (mean ± SD) TMD TMD - painDETECT
all (n = 19) ≤ 12 (n = 12) 13–18 (n = 3) ≥ 19 (n = 4)
present pain (NRS) 2.9 ± 0.5 3.2 ± 0.7 3.7 ± 1.2 1.8 ± 0.9
maximal pain - last week (NRS) 4.3 ± 0.6 4.6 ± 0.7 6.7 ± 1.1 1.8 ± 0.7
minimal pain - last week (NRS) 2.4 ± 0.4 2.7 ± 0.6 2.3 ± 0.7 1.5 ± 0.8
pain estimation BPQ 25 (1–13)/ sensory 8.1 ± 1.6 4.8 ± 1.1 18.3 ± 3.1 9.3 ± 2.9
pain estimation BPQ 25 (14–17)/ affective 3.5 ± 0.7 3.5 ± 1.0 3.7 ± 1.4 3.5 ± 1.3
pain estimation BPQ 25 (18–19)/ evaluative 2.7 ± 0.5 2.3 ± 0.6 4.3 ± 0.7 2.8 ± 1.2
pain estimation BPQ 25 (18 + 19 + 20/2)/ affective-evaluative 1.6 ± 0.3 1.4 ± 0.4 2.3 ± 0.3 1.5 ± 0.7
pain since 1–2 y 1–2 y 6–12 m 2–5 y
inability to work due to pain 12% (1–2 d) 45% (1d) 67% (> 50 d) 25% (1–5 d)
reduction of activity due to pain (work) 39% 36% 43% 48%
reduction of activity due to pain (leisure) 44% 46% 43% 40%
additonal pain in other body regions 67% 55% 67% 100%
pain-free time min-h min h d
NRS Numeric rating scale, BPQ Berne pain questionnaire (number 1–13 comprising sensory adjectives, maximum value 50; 14–17 comprising affective adjectives,
maximum value 17; 18–19 comprising evaluative adjectives, maximum value 7; 20 comprising affective-evaluative adjectives, maximum value 5.5)
Table 3 Psychological Comorbidity of TMD patients (TMD all and according to their painDETECT scores (≤ 12, n = 12; 13–18, n = 3;
≥ 19, n = 4))
Psychological comorbidity Healthy subjects TMD TMD - painDETECT
(n = 38) all (n= 19) p-value ≤ 12 (n= 12) p-value 13–18 (n= 3) p-value ≥ 19 (n= 4) p-value
anxiety (HADS-D) mean ± SD 5.0 ± 3 7.3 ± 5 0.082 7.1 ± 4.5 0.102 5.3 ± 3.1 0.865 9.3 ± 7.0 0.034*
< 8 n = 32 n = 12 n = 8 n = 2 n = 2
8–10 n = 4 n = 0 n = 0 n = 0 n = 0
> 10 n = 2 n = 6 n = 3 n = 1 n = 2
depression (HADS-D) mean ± SD 2.2 ± 2.5 6.4 ± 4.3 0.001** 6.6 ± 5.1 0.000*** 5.3 ± 3.1 0.105 7.0 ± 3.2 0.006**
< 8 n = 37 n = 10 n = 6 n = 2 n = 2
8–10 n = 1 n = 5 n = 2 n = 1 n = 2
> 10 n = 0 n = 3 n = 3 n = 0 n = 0
diverting attention (CSQ1) mean ± SD 2.9 ± 1.1 3.3 ± 0.3 0.335 3.3 ± 1.4 0.423 3.4 ± 2 0.592 3.3 ± 1.6 0.634
reinterpreting pain sensation (CSQ2) mean ± SD 2.2 ± 1 2.0 ± 0.2 0.584 2.2 ± 1.1 0.983 1.7 ± 1.1 0.499 1.7 ± 0.5 0.434
coping self-statement (CSQ3) mean ± SD 3.7 ± 1.1 4.3 ± 0.4 0.157 4.2 ± 2 0.306 3.8 ± 0.5 0.932 4.9 ± 0.8 0.108
ignoring sensation (CSQ4) mean ± SD 3.3 ± 1.2 3.3 ± 0.3 0.960 3.5 ± 1.8 0.783 2.3 ± 1.2 0.229 3.8 ± 1 0.497
praying and hoping (CSQ5) mean ± SD 2.6 ± 1.3 3.0 ± 0.3 0.314 2.5 ± 1.4 0.872 3.1 ± 0.8 0.481 4.1 ± 0.9 0.030*
catastrophizing (CSQ6) mean ± SD 2.0 ± 1.1 3.3 ± 0.4 0.022* 3.6 ± 2.1 0.006** 3.2 ± 2.1 0.193 2.6 ± 1.8 0.503
increased behaviour activities (CSQ7) mean ± SD 3.5 ± 1.5 4.3 ± 0.3 0.080 4.1 ± 1.5 0.328 5.4 ± 0.8 0.044* 4.3 ± 1.6 0.320
pain behaviour (CSQ8) mean ± SD 4.0 ± 1 3.7 ± 0.3 0.473 3.2 ± 1.2 0.055 5.1 ± 1.5 0.089 4.0 ± 0.6 0.967
HADS-D Hospital anxiety and depression scale, anxiety in mean value ± SD or divided in subgroups concerning their severity (< 8, 8–10, > 10),
depression in mean value ± SD CSQ = Coping strategies in mean value ± SD; p-value for TMD all as results of unpaired t-test as related to healthy
subjects considering the Levene’s test for equality of variances; p-value according to the painDETECT scores as results of analysis of variance (ANOVA)
with LSD post hoc correction of multiple comparison (*p < 0.05; **p < 0.01; ***p < 0.001)
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reason for chronification of TMD [18, 32], we focused
our attention not only on the signs of sensory gain (pres-
sure, cold and heat hyperalgesia), but on psychological
comorbidity of the TMD patients. We found that the pa-
tients with painDETECT scores ≥ 19 also showed the
highest values for anxiety, depression, praying and hop-
ing among all TMD patients.
In clinical examination we revealed no abnormalities in
facial mimic expression for all TMD patients, but found
pain sensitivity for mandibular movement and upon pal-
pation of different muscles, the temporomandibular joint
and the trigeminal foramina. Relating to clinical examin-
ation, we found a positive relationship between the in-
creased sensitivity during masseter palpation and higher
painDETECT scores. In the “painDETECT ≥ 19” group,
the higher pain upon masseter palpation could be con-
firmed by measurement of pressure pain thresholds (PPT)
in the Quantitative Sensory Testing (QST).
Our findings are supported by other studies in which
several patients with chronic temporomandibular dis-
order were found to be more sensitive to painful stimuli
than other patients or healthy subjects. Pfau et al., for
example, distinguished a “sensitive” and an “insensitive”
TMD subgroup with regard to their tenderness on
palpation of orofacial muscles and trigeminal foramina
and could confirm this hyperalgesia using QST [11].
Likewise, de Sequeira et al. assessed sensory characteris-
tics of patients with chronic pain involving a combin-
ation of thermal, mechanical pain stimuli and found the
majority of patients (73.3%) with pain upon craniofacial
muscle palpation [33]. Several other research groups
perceived the diagnostic value of pressure pain threshold
analysis for TMD as well [14, 34–36]. QST is a method
to investigate pressure pain thresholds and, therefore, is
a useful component in mechanism-based classification
of TMD. It is frequently mentioned for pain assessment
and diagnosis in the orofacial region [36–40].
The fact that only the “painDETECT ≥ 19” group
showed significantly decreased QST pressure pain
thresholds (PPT), underlines the effective use of the
painDETECT questionnaire in the differentiated analysis
of TMD subgroups.
Until now the painDETECT questionnaire has not been
validated for the trigeminal region. In accordance with our
study, the painDETECT questionnaire was assessed for
detecting neuropathic pain in patients with post-traumatic
inferior alveolar nerve injury (IANI) and lingual nerve in-
jury (LNI) [41]. The authors concluded the painDETECT
questionnaire not to be suitable for screening IANI or
LNI. Heo et al. 2015 found the painDETECT question-
naire, although not being an ideal principal screening tool
for burning mouth syndrome (BMS), could still be useful
to identify a substantial proportion of neuropathic symp-
toms in primary BMS patients [42].
In addition to the significantly increased PPT, a signifi-
cant hyperalgesia against cold and heat painful stimuli
could be revealed for patients with chronic TMD and
painDETECT scores ≥ 19. Such an increased sensitivity
against cold and heat pain, in addition to pressure hyper-
algesia, was also found for the “sensitive” TMD pain group
as distinguished by Pfau et al. 2009 [11], showing more
than 11/18 tender points according to the former diagnos-
tic criteria for FMS. As results from both the “sensitive”
and the “painDETECT ≥ 19” TMD subgroup show that
the pain is not only present in the area of the trigeminal
nerve, but throughout the whole body, changes involving
the central nervous system should be considered [43].
Central sensitisation might arise as a result of insufficient
endogenous descending inhibition [18–20]. Persistent psy-
chosocial stress and increased mental vulnerability, as
found within the patients with painDETECT scores ≥ 19,
may, therefore, be the cause [21, 32, 44]. This can explain
the spreading of pain throughout the body and the in-
crease during examination. The low subjective pain rating
of these patients can be interpreted as adaption to the
chronic pain state, although habituation to pain is not
known. In addition, the “sensitive” and “painDETECT
≥ 19” group both show high levels of anxiety and depres-
sion, further evidence for central sensitisation. Therefore,
we assume psychosocial factors to be one reason for
chronification in both groups.
In our study, the painDETECT questionnaire enables
the identification of subgroups of patients with chronic
TMD showing different severity in induced pressure,
cold and heat pain. Nevertheless, the neurobiological
basis for this is not fully elucidated, but as we found psy-
chological comorbidity for the patients, we assume
stress-induced hyperalgesia to be the reason [45, 46].
Thermal hyperalgesia may be triggered by a stimulation
of the dorsomedial hypothalamic nucleus, whereby the
rostral ventromedial medulla plays an important role by
activating so-called “ON-cells” that amplify the nocicep-
tive input. This part of the brain is also responsible for
allodynia and hyperalgesia in neuropathic pain [19].
Moreover, a number of other long-lasting changes in the
neural system are probably involved in brain activity.
The dysfunction of the hypothalamic-pituitary-adrenal
axis (HPA axis) and various neurotransmitter systems in
the brain, including the endogenous opioid system and
the serotonergic and noradrenergic systems, have been
demonstrated in animal experiments to be relevant factors
[20]. Chronic TMD might be caused by hypersensitivity of
the nervous system and central sensitization [47].
In our study we found all TMD patients showing signs
of depression and anxiety. The scores were higher in
TMD patients with increased painDETECT scores
(≥ 19). In contrast to our findings, Reiter et al. analysed
a less significant role of anxiety in patients with chronic
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TMD compared to depression and somatization [48]. Yu
et al. 2015, however, detected high anxiety (OR 2.48;
95% CI 1.25–4.90) as the most significant factor associ-
ated with TMD. Among other publications indicating
psychological stress to be significantly associated with
TMD [49], Ismail et al. 2015 found clinical symptoms of
depression in 16% of the TMD patients. They recom-
mend the use of screening tools for psychological disor-
ders on a regularly basis when evaluating TMD patients.
Psychological stress is a risk factor for the development
of a painful TMD [50]. The effects of stress on pain vary
according to duration of exposure, mental and biological
vulnerability of the individual and age at exposition.
Effects are most pronounced in individuals whose gen-
etic susceptibility increases responsiveness to catechol-
amine neurotransmitters [50]. Furthermore the large
prospective OPPERA (Orofacial Pain: Prospective Evalu-
ation and Risk Assessment) study found psychological
variables to predict first onset of TMD [51]. Therefore,
informing and educating patients about pain perception
and functional jaw opening becomes essential in order
to decrease fear and depression concerning TMD and to
improve jaw function and quality of life [52].
Conclusion
In our study we were able to prove the painDETECT
questionnaire to be helpful as an additional diagnostic
tool, which, together with QST, can reveal hyperalgesia
for pressure (PPT) and thermal sensation (CPT, HPT) in
chronic TMD patients. High painDETECT scores (≥ 19)
correlate with decreased pain levels for pressure and
thermal sensation in QST. As TMD patients of the pain-
DETECT group ≥ 19 have additional pain in other parts
of the body, suggesting central sensitization [53], we
would recommend testing also an extra oral site when
performing QST in these patients, for example the dor-
sum of the hand. An obvious limitation in the present
study was the small number of patients, especially in the
painDETECT 13–18 (n = 3) and ≥ 19 (n = 4) group.
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